Compare Charles River Laboratories Intl. Inc (CRL) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Sibanye Stillwater Ltd — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Sibanye Stillwater Ltd trades at $10 (market cap $6.88B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.1× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays a 8.17% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Sibanye Stillwater Ltd for 51 Days on average.
| CRL | SBSW | |
|---|---|---|
Market Cap | $14.23B | $6.88B |
Volume | 1,176,885 | 4,474,536 |
Sector | Health | Basic Materials |
52-Week High | $310.77 | $21.12 |
52-Week Low | $149.93 | $8.00 |
Typical Hold Time | 33 Days | 51 Days |
Enterprise Value | $17.06B | $7.78B |
Dividend Yield | — | 8.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
Sibanye Stillwater (SBSW) trades at $9.91, up 2.38% today, showing mixed technical signals with a bearish overall trend but neutral oscillators. Fundamentally, the company reported strong revenue growth to $129.68 billion in 2025 with improving margins, though net income remains negative. Recent Q2 2026 earnings beat expectations with EPS of $1.34 versus $1.26 expected, indicating operational momentum. Analyst sentiment is cautiously optimistic with a Moderate Buy consensus and $14.25 price target representing 44% upside potential.
The stock presents a turnaround opportunity with attractive valuation metrics (P/E 8.12, P/S 0.7) and strong cash flow generation, but faces risks from volatile commodity prices and persistent negative earnings. Institutional ownership is growing with recent 81.4% position increase by MAC Alpha Capital. The key catalyst remains sustained profitability improvement and execution of the 2027-2028 growth roadmap.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
